Inhibition of cell-cycle effectors of proliferation in bladder tumor epithelial cells by the p75NTR tumor suppressor

Molecular Carcinogenesis

Volumn 36, Issue 3, 2003, Pages 153-160

  Khwaja, Fatima ^a   Djakiew, Daniel ^a,b  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

Author keywords

Cell cycle; p75NTR; Tumor suppressor

Indexed keywords

CYCLINE; NEUROTROPHIN RECEPTOR; PROTEIN P75; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F;

ARTICLE; BLADDER CANCER; CANCER GROWTH; CANCER INHIBITION; CELL CLONING; CELL CYCLE; CELL CYCLE S PHASE; CELL PROLIFERATION; DOSE RESPONSE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CDC2-CDC28 KINASES; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIVISION; CYCLIN D1; CYCLIN E; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASES; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; EPITHELIAL CELLS; GENES, TUMOR SUPPRESSOR; NERVE GROWTH FACTOR; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEIN-SERINE-THREONINE KINASES; RECEPTOR, NERVE GROWTH FACTOR; RECEPTORS, NERVE GROWTH FACTOR; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 0037335571     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/mc.10106     Document Type: Article

References (28)

1. Chao MV. The p75 neurotrophin receptor. J Neurobiol 1994; 25:1373-1385.
2. Chapman BS. A region of the 75 kDa neurotrophin receptor homologous to the death domains of TNFR-I and Fas. FEBS Lett 1995;374:216-220.
3. Vaidyanathan S, Krishnan KR, Mansour P, Soni BM, McDicken I. p75 nerve growth factor receptor in the vesical urothelium of patients with neuropathic bladder: An immunohistochemical study. Spinal Cord 1998;36:541-547.
4. Huber LJ, Chao MV. Mesenchymal and neuronal cell expression of the p75 neurotrophin receptor gene occur by different mechanisms. Dev Biol 1995;167:227-238.
5. NTR and Trk in prostate cancer. In: Mocchetti FP, ed. Neurobiology of the Neurotrophins, 1st edition. Mountain Home, Tennessee: Graham Publishing Co., 2000; 525-537.
6. NTR is a tumor suppressor in human prostate cancer. Anticancer Res 2001;21:3749-3755.
7. Tanner R, Chambers P, Khadra MH, Gillespie JI. The production of nerve growth factor by human bladder smooth muscle cells in vivo and in vitro. BJU Int 2000;85:1115-1119.
8. Clemow DB, Steers WD, Tuttle JB. Stretch-activated signaling of nerve growth factor secretion in bladder and vascular smooth muscle cells from hypertensive and hyperactive rats. J Cell Physiol 2000;183:289-300.
9. NTR suppresses growth and nerve growth factor-mediated metastasis of human prostate cancer cells. Int J Cancer 2002;98: 1-7.
10. Sellers WR, Kaelin WG. RB [corrected] as a modulator of transcription. Biochim Biophys Acta 1996;1288:M1-M5.
11. Huang Z, Tang XM, Cambi F. Down-regulation of the retinoblastoma protein (Rb) is associated with rat oligodendrocyte differentiation. Mol Cell Neurosci 2002;19:250-262.
12. Pestell RG, Albanese C, Reutens AT, Segall JE, Lee RJ, Arnold A. The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation. Endocr Rev 1999;20:501-534.
13. Sherr CJ. Cancer cell cycles. Science 1996;274:1672-1677.
14. Ortega S, Malumbres M, Barbacid M. Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim Biophys Acta 2002;1602:73-87.
15. Matsushime H, Ewen ME, Strom DK, et al. Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins. Cell 1992;71:323-334.
16. van Bokhoven A, Varella-Garcia M, Korch C, Miller GJ. TSU-Pr1 and JCA-1 cells are derivatives of T24 bladder carcinoma cells and are not of prostatic origin. Cancer Res 2001;61: 6340-6344.
17. NTR in a human prostate epithelial tumor cell line reduces nerve growth factor-induced cell growth by activation of programmed cell death. Mol Carcinog 1998;23:106-114.
18. Pflug BR, Onoda M, Lynch JH, Djakiew D. Reduced expression of the low affinity nerve growth factor receptor in benign and malignant human prostate tissue and loss of expression in four human metastatic prostate tumor cell lines. Cancer Res 1992;52:5403-5406.
19. Pagano M, Pepperkok R, Lukas J, et al. Regulation of the cell cycle by the cdk2 protein kinase in cultured human fibroblasts. J Cell Biol 1993;121:101-111.
20. Andersen NA, Larsen CM, Mandrup-Poulsen T. TNFalpha and IFNgamma potentiate IL-1beta induced mitogen activated protein kinase activity in rat pancreatic islets of Langerhans. Diabetologia 2000;43:1389-1396.
21. Meyer CA, Jacobs HW, Lehner CF. Cyclin d-cdk4 is not a master regulator of cell multiplication in Drosophila embryos. Curr Biol 2002;12:661-666.
22. Sherr CJ. Mammalian G1 cyclins. Cell 1993;73:1059-1065.
23. Sherr CJ. The INK4a/ARF network in tumour suppression. Nature Rev 2001;2:731-737.
24. Shintani S, Mihara M, Nakahara Y, et al. Expression of cell cycle control proteins in normal epithelium, premalignant and malignant lesions of oral cavity. Oral Oncol 2002;38: 235-243.
25. Porter LA, Dellinger RW, Tynan JA, et al. Human speedy: A novel cell cycle regulator that enhances proliferation through activation of Cdk2. J Cell Biol 2002;157:357-366.
26. Jackman M, Kubota Y, den Elzen N, Hagting A, Pines J. Cyclin A- and Cyclin E-Cdk complexes shuttle between the nucleus and the cytoplasm. Mol Biol Cell 2002;13:1030-1045.
27. Harbour JW, Dean DC. The Rb/E2F pathway: Expanding roles and emerging paradigms. Genes Dev 2000;14:2393-2409.
28. Westwood G, Dibling BC, Cuthbert-Heavens D, Burchill SA. Basic fibroblast growth factor (bFGF)-induced cell death is mediated through a caspase-dependent and p53-independent cell death receptor pathway. Oncogene 2002;21: 809-824.